Last update 15 Sep 2025

RT-200

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
AAV based urocortin 2 gene therapy (Renova Therapeutics), RT-200
Target
UCN2
Action-
Mechanism
UCN2 gene transference(urocortin 2 gene transference)
Therapeutic Areas
Cardiovascular DiseasesDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2Abdominal Obesity Metabolic SyndromeHeart Failure+ [2]
Inactive Indication-
Originator Organization
Renova Therapeutics, Inc.Renova Therapeutics, Inc.
Active Organization
Renova Therapeutics, Inc.Renova Therapeutics, Inc.CLAYTON BIOTECHNOLOGIES, INC.CLAYTON BIOTECHNOLOGIES, INC.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with RT-200
Login to view more data
100 Translational Medicine associated with RT-200
Login to view more data
100 Patents (Medical) associated with RT-200
Login to view more data
100 Deals associated with RT-200
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Preclinical
United States
CLAYTON BIOTECHNOLOGIES, INC.CLAYTON BIOTECHNOLOGIES, INC.
01 Aug 2025
Abdominal Obesity Metabolic SyndromePreclinical
United States
Renova Therapeutics, Inc.Renova Therapeutics, Inc.
-
Heart FailurePreclinical
United States
Renova Therapeutics, Inc.Renova Therapeutics, Inc.
-
Nonalcoholic SteatohepatitisPreclinical
United States
Renova Therapeutics, Inc.Renova Therapeutics, Inc.
-
ObesityPreclinical
United States
Renova Therapeutics, Inc.Renova Therapeutics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free